Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of H2BC18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 1937.49 | 234 / 245 | 93% | 6.76 | 466 / 502 |
ovary | 84% | 1772.22 | 152 / 180 | 85% | 3.26 | 366 / 430 |
lung | 80% | 1592.15 | 464 / 578 | 63% | 2.76 | 731 / 1155 |
esophagus | 42% | 214.21 | 600 / 1445 | 80% | 3.28 | 146 / 183 |
bladder | 62% | 333.81 | 13 / 21 | 58% | 3.61 | 292 / 504 |
breast | 42% | 343.26 | 195 / 459 | 67% | 4.00 | 752 / 1118 |
stomach | 55% | 312.36 | 196 / 359 | 50% | 2.14 | 143 / 286 |
uterus | 41% | 506.41 | 69 / 170 | 56% | 2.30 | 259 / 459 |
kidney | 74% | 494.60 | 66 / 89 | 23% | 0.74 | 204 / 901 |
thymus | 61% | 343.92 | 401 / 653 | 32% | 0.68 | 191 / 605 |
pancreas | 25% | 95.40 | 83 / 328 | 61% | 2.85 | 109 / 178 |
peripheral blood | 84% | 3563.52 | 778 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 52% | 115.12 | 134 / 258 | 28% | 0.60 | 64 / 230 |
skin | 54% | 459.98 | 980 / 1809 | 24% | 0.51 | 112 / 472 |
spleen | 77% | 805.52 | 186 / 241 | 0% | 0 | 0 / 0 |
intestine | 40% | 261.20 | 386 / 966 | 36% | 1.49 | 191 / 527 |
brain | 43% | 127.88 | 1139 / 2642 | 32% | 0.71 | 226 / 705 |
liver | 44% | 228.88 | 100 / 226 | 19% | 0.64 | 78 / 406 |
heart | 38% | 174.01 | 326 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 29% | 162.34 | 386 / 1335 | 0% | 0 | 0 / 0 |
adipose | 28% | 270.12 | 342 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.40 | 7 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.33 | 8 / 45 |
eye | 0% | 0 | 0 / 0 | 11% | 0.20 | 9 / 80 |
muscle | 4% | 10.59 | 29 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000786 | Cellular component | nucleosome |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003677 | Molecular function | DNA binding |
GO_0030527 | Molecular function | structural constituent of chromatin |
GO_0003674 | Molecular function | molecular_function |
Gene name | H2BC18 |
Protein name | Histone H2B type 2-F (H2B-clustered histone 18) |
Synonyms | HIST2H2BF |
Description | FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Accessions | ENST00000369167.3 [Q5QNW6-1] ENST00000545683.1 [Q5QNW6-2] Q5QNW6 |